V3V
VITA 34 AG
Save
84.37M
Market cap
–
Current P/E
–
Forward P/E
About
Health care
Sector
Medical Care Facilities
Industry
VITA 34 AG engages in the collection, processing, and cryopreservation of stem cells from umbilical cord blood and tissue in Germany, Poland, Portugal, and internationally. It also develops products and drugs based on cells, tissues, and blood for medical applications; and produces viral vectors and CAR-T cells. The company manufactures advanced therapy medicinal products for third parties.
Similar securities
Based on sector and market capitalization
Report issue